Choom (OTCMKTS:CHOOF) and ANI Pharmaceuticals (NASDAQ:ANIP) Head-To-Head Review

ANI Pharmaceuticals (NASDAQ:ANIPGet Free Report) and Choom (OTCMKTS:CHOOFGet Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability.

Analyst Ratings

This is a summary of recent ratings and target prices for ANI Pharmaceuticals and Choom, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANI Pharmaceuticals 0 1 5 0 2.83
Choom 0 0 0 0 N/A

ANI Pharmaceuticals presently has a consensus price target of $77.00, indicating a potential upside of 29.89%.

Profitability

This table compares ANI Pharmaceuticals and Choom’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ANI Pharmaceuticals 5.01% 15.64% 7.63%
Choom N/A N/A N/A

Valuation & Earnings

This table compares ANI Pharmaceuticals and Choom”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ANI Pharmaceuticals $538.95 million 2.31 $18.78 million $1.60 37.05
Choom N/A N/A N/A $0.14 N/A

ANI Pharmaceuticals has higher revenue and earnings than Choom. Choom is trading at a lower price-to-earnings ratio than ANI Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 12.7% of ANI Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

ANI Pharmaceuticals beats Choom on 9 of the 9 factors compared between the two stocks.

About ANI Pharmaceuticals

(Get Free Report)

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

About Choom

(Get Free Report)

Choom Holdings Inc. engages in the retail of cannabis. It sells cannabis products and accessories. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Receive News & Ratings for ANI Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANI Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.